BCA
EXAS

Bray Capital Advisors’s Exact Sciences EXAS Stock Holding History

Bray Capital Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-90
Closed -$6K – 274
2022
Q1 		$6K Hold
90
– – ﹤0.01% 258
2021
Q4 		$7K Hold
90
– – ﹤0.01% 251
2021
Q3 		$9K Buy
+90
New +$9.5K ﹤0.01% 244

Other funds holding EXAS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bray Capital Advisors's EXAS Position: Q2 2022 in Review

Bray Capital Advisors sold out of Exact Sciences (EXAS) in Q2 2022, closing a stake of 90 shares — an estimated $6K sold.

Bray Capital Advisors first reported a position in EXAS in Q3 2021 and held it in 3 quarters. The position peaked at $9K in Q3 2021. 501 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.

  • Bray Capital Advisors reported no remaining Exact Sciences position as of Q2 2022 after selling out during the quarter.
  • Bray Capital Advisors sold 90 Exact Sciences shares in Q2 2022, an estimated $6K.
  • Bray Capital Advisors first reported a position in Exact Sciences in Q3 2021 and held it in 3 quarters.
  • Bray Capital Advisors's Exact Sciences position peaked at $9K in Q3 2021.
  • 501 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.

Based on Bray Capital Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.